Key Features: Investigational Compound : GLP-1 S (10mg) is intended to support research into the pharmacodynamics and pharmacokinetics of GLP-1 receptor agonists
Severe or Disruptive: Interfering with daily activities or sleep
To name just a few: fatigue, breathlessness, dizziness, diarrhoea, dementia, depression, tachycardia, swollen and sore joints, blurred vision, pain and numbness (or burning) in hands and feet, sore muscles, sore tongue, inability to walk (later)
I don't need it every 3-6 months
But we cant look at someone and determine that they have this diagnosis. Alarmingly, 26% of GPs in Healtheds survey had encountered at least one patient who had obtained a GLP-1 script they thought was not appropriate
FAQ about Semaglo (Semaglutide)/ OZEMPIC Generic Semaglutide: Q